Home > Insider Trading > Filing (0001104659-19-043306)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886163	Ligand Pharmaceuticals Inc	LGND	Pharmaceutical Preparations (2834)	770160744

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1442372	L Stephen Sabba	Dorset Management Corp 485 Underhill Blvd Suite 205 Syosset NY 11791		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-07-31	4,091	$94.45	23,600	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These securities, as represented in Column 5, include restricted shares comprised of: (a) a grant of 835 restricted shares in a transaction exempt from Section 16b treatment, as originally reported on a Form 4 filed June 10, 2019, which shares will vest in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date; and (b) fully vested restricted shares granted in respective transactions, each exempt from Section 16b treatment and reported on previously filed Form 4s for the Reporting Person.
The price reported is based on an average share price from the following transactions: ((767 shares @ $96.0691)+(100 shares @ $95.605)+(600 shares @ $95.438334)+(2,624 shares @ $93.70))/ 4,091 shares. The price reported has been rounded from $94.4456857 for formatting purposes.